News
If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...
This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
Trump told Time magazine in December he would not restrict access to abortion medication. On the campaign trail, the ...
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or ...
Food and Drug Administration Commissioner Marty Makary, M.D., spoke about the need to shorten the length of the drug approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results